Pipeline

Advantagene (d.b.a. Candel Therapeutics) has ongoing clinical trials at study sites throughout the U.S. The company’s experimental therapies target unmet medical needs, have strong scientific justification, short-term endpoints and favorable competitive positions. Advantagene is committed to the development of future clinical trials for other indications as resources permit.

Advantagene, Inc.

Address

117 Kendrick Street,

Suite 450

Needham,

Massachusetts 02494

Contact

6179165445

Follow

©2020 by Advantagene